Identification of “Multiple Components-Multiple Targets-Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology

Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet

(2013) Jingjing Zhao et al.   CURRENT PHARMACEUTICAL DESIGN

BNC Protects H9c2 Cardiomyoblasts from H2O2-Induced Oxidative Injury through ERK1/2 Signaling Pathway

(2013) Fangbo Zhang et al.   Evidence-based Complementary and Alternative Medicine

New Therapeutic Targets in Cardiology

(2012) Eva Denise Martin et al.   CIRCULATION

Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis

(2011) Joseph R. Burgoyne et al.   FASEB JOURNAL

Nuclear receptors as drug targets for metabolic disease

(2010) Ira G. Schulman   ADVANCED DRUG DELIVERY REVIEWS

Isoform- and tissue-specific regulation of the Ca2+-sensitive transcription factor NFAT in cardiac myocytes and heart failure

(2010) Andreas Rinne et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1α

(2009) Chiu-Mei Lin et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Network pharmacology: the next paradigm in drug discovery

(2008) Andrew L Hopkins   Nature Chemical Biology